Clinical Trials Logo

Clinical Trial Summary

The purpose of the study is to determine the feasibility, safety and efficacy of administering rapidly-generated donor-derived pentavalent-specific T cells (Penta-STs) to mediate antiviral and antifungal activity in hematopoietic stem cell transplant (HSCT) recipients with AdV, EBV, CMV, BKV or Aspergillus fumigatus (AF) infection/ reactivation or with active disease.


Clinical Trial Description

Reconstitution of anti-viral and antifungal immunity by donor-derived antigen-specific T cells has shown promise in preventing and treating infections with CMV, or/and EBV, or/and AdV or/and BKV, HHV6 or/and AF post-transplant. However, the broader implementation of T cell immunotherapy using conventional protocols is limited and until today it was practically impossible for Greece by the cost, the complexity and the time required for virus-specific T cells (VSTs) production and by the antigenic competition between different antigens, which limits the spectrum of viruses that can be targeted in a single T cell product. In this trial, the investigators will evaluate the feasibility, safety and efficacy of donor-derived Penta-STs infusion to allogeneic HSCT recipients with confirmed AdV, EBV, CMV, BKV and AF infection. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05471661
Study type Interventional
Source George Papanicolaou Hospital
Contact Evangelia Yannaki, MD
Phone +302313307518
Email eyannaki@uw.edu
Status Recruiting
Phase Phase 1/Phase 2
Start date January 24, 2022
Completion date April 30, 2023

See also
  Status Clinical Trial Phase
Completed NCT04687982 - Feasibility and Efficacy of Modified Donor Lymphocytes Infusion (CD45RA Negative Selected) After Haploidentical Transplantation With Post-transplantation Cyclophosphamide in Patients With Hematological Malignancies (ONC-2016-002). N/A
Completed NCT02263703 - Immunogenicity of HPV Vaccine in Immunosuppressed Children Phase 3
Active, not recruiting NCT02804464 - The DISCOVER Trial (Diagnosis of Infection in Stem Cell Transplant Patients OVER Time)
Completed NCT02032381 - Prospective Study of Belated Pulmonary Complications Occurring in Children Treated With Allogeneic Hematopoietic Stem Cells. N/A
Not yet recruiting NCT04709848 - Strongyloides Stercoralis in Bone Marrow Transplant Recipients in the UK
Completed NCT04892160 - Distracting Through Procedural Pain and Distress N/A
Active, not recruiting NCT03180216 - T-Lymphocytes for Prevention or Treatment of Viral Infections Following Hematopoietic Stem Cell Transplantation Phase 1
Completed NCT01502072 - Respiratory Syncytial Virus - RSV Protocol Phase 2